Sentinel node biopsy for early oral carcinoma

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 20, Issue 2, 2012, Pages

  Stoeckli, Sandro J ^a   Broglie, Martina A ^a  

^a Kantonsspital St Gallen ^*  (Switzerland)

Author keywords

head and neck; lymphoscintigraphy; micrometastasis; oral cancer; sentinel node biopsy

Indexed keywords

CANCER STAGING; EARLY CANCER; FOLLOW UP; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; MORBIDITY; MOUTH CARCINOMA; NECK DISSECTION; OBSERVATIONAL STUDY; ORAL SQUAMOUS CELL CARCINOMA; PEROPERATIVE CARE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENTINEL NODE BIOPSY; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

CARCINOMA, SQUAMOUS CELL; FROZEN SECTIONS; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MOUTH NEOPLASMS; NECK; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 84859108615     PISSN: 10689508     EISSN: 15316998     Source Type: Journal    
DOI: 10.1097/MOO.0b013e32834ef6d3     Document Type: Review

References (63)

1. van den Brekel MW. Lymph node metastases: CTand MRI. Eur J Radiol 2000; 33:230-238.
2. Curtin HD, Ishwaran H, Mancuso AA, et al. Comparison of CT and MR imaging in staging of neck metastases. Radiology 1998; 207:123-130. (Pubitemid 28168675)
3. Stoeckli SJ, Steinert H, Pfaltz M, Schmid S. Is there arole for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 2002; 24:345-349. (Pubitemid 34260038)
4. Pentenero M, Cistaro A, Brusa M, et al. Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma. Head Neck 2008; 30:1488-1496.
5. Stoeckli SJ, Alkureishi LW, Ross GL. Sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2009; 266:787-793.
6. Stoeckli SJ, Haerle SK, Strobel K, et al. Initial staging of the neck in head and neck squamous cell carcinoma: a comparison of CT, PET/CT, and ultrasound-guided fine-needle aspiration cytology. Head Neck 2011. [Epub ahead of print]
7. Yuen AP, Ho CM, Chow TL, et al. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck 2009; 31:765-772.
8. van den Brekel MW, van der Waal I, Meijer CJ, et al. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 1996; 106:987-991. (Pubitemid 26287241)
9. Byers RM, Wolf PF, Ballantyne AJ. Rationale for elective modified neck dissection. Head Neck Surg 1988; 10:160-167. (Pubitemid 19093833)
10. Shoaib T, Soutar DS, MacDonald DG, et al. The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck. Cancer 2001; 91:2077-2083. (Pubitemid 32476372)
11. Stoeckli SJ, Steinert H, Pfaltz M, Schmid S. Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2001; 125:221-226. (Pubitemid 33662671)
12. Mozzillo N, Chiesa F, Botti G, et al. Sentinel node biopsy in head and neck cancer. Ann Surg Oncol 2001; 8 (9 Suppl):103S-105S.
13. Dunne AA, Kulkens C, Ramaswamy A, et al. Value of sentinel lymphonodectomy in head and neck cancer patients without evidence of lymphogenic metastatic disease. Auris Nasus Larynx 2001; 28:339-344. (Pubitemid 33009266)
14. Stoeckli SJ. Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma of the head and neck. Laryngoscope 2007; 117:1539-1551. (Pubitemid 47357381)
15. Ross GL, Soutar DS, Gordon MacDonald D, et al. Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol 2004; 11:690-696. (Pubitemid 40486704)
16. Stoeckli SJ, Pfaltz M, Ross GL, et al. The second international conference on sentinel node biopsy in mucosal head and neck cancer. Ann Surg Oncol 2005; 12:919-924. (Pubitemid 41504225)
17. Ross GL, Shoaib T, Soutar DS, et al. The First International Conference on Sentinel Node Biopsy in Mucosal Head and Neck Cancer and adoption of a multicenter trial protocol. Ann Surg Oncol 2002; 9:406-410. (Pubitemid 34496730)
18. Paleri V, Rees G, Arullendran P, et al. Sentinel node biopsy insquamous cell cancer of the oral cavity and oral pharynx: a diagnostic meta-analysis. Head Neck 2005; 27:739-747. (Pubitemid 41266177)
19. Alkureishi LW, Burak Z, Alvarez JA, et al. Joint practice guidelines for radio-nuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol 2009; 16:3190-3210.
20. Civantos FJ, Zitsch RP, Schuller DE, et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multiinstitutional trial. J Clin Oncol 2010; 28:1395-1400. This is a large-scale prospective multicentric validation study of SNB in OSCC which showed an excellent reliability of the technique, and opened the way in the USA.
21. Broglie MA, Haile SR, Stoeckli SJ. Long-term experience in sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Ann Surg Oncol 2011. [Epub ahead of print] Long-term follow-up of one of the large European observational trials confirming the accuracy of SNB for OSCC and showing a survival benefit for sentinel nodenegative patients.
22. Alkureishi LW, Ross GL, Shoaib T, et al. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol 2010; 17:2459-2464. Long-term follow-up of the other large European observational trial of SNB for OSCC, confirming the accuracy of the technique.
23. Kovacs AF, Stefenelli U, Seitz O, et al. Positive sentinel lymph nodes are a negative prognostic factor for survival in T1-2 oral/oropharyngeal cancer-a long-term study on 103 patients. Ann Surg Oncol 2009; 16:233-239.
24. Terada A, Hasegawa Y, Yatabe Y, et al. Follow-up after intraoperative sentinel node biopsy of N0 neck oral cancer patients. Eur Arch Otorhinolaryngol 2011; 268:429-435.
25. Saltman BE, Ganly I, Patel SG, et al. Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma. Head Neck 2010; 32:1686-1692.
26. Carlson GW, Page AJ, Cohen C, et al. Regional recurrence after negative sentinel lymph node biopsy for melanoma. Ann Surg 2008; 248:378-386.
27. Rosenberg R, Friederichs J, Gertler R, et al. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int J Colorectal Dis 2004; 19:430-437. (Pubitemid 39193808)
28. Civantos FJ, Stoeckli SJ, Takes RP, et al. What is the role of sentinel lymph node biopsy in the management of oral cancer in 2010? Eur Arch Otorhinolaryngol 2010; 267:839-844.
29. Rogers SN, Ferlito A, Pellitteri PK, et al. Quality of life following neck dissections. Acta Otolaryngol 2004; 124:231-236. (Pubitemid 38580849)
30. van Wilgen CP, Dijkstra PU, Nauta JM, et al. Shoulder pain and disability in daily life, following supraomohyoid neck dissection: a pilot study. J Craniomaxillofac Surg 2003; 31:183-186. (Pubitemid 36790153)
31. Murer K, Huber GF, Haile SR, Stoeckli SJ. Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the N0neck in patients with oral squamous cell carcinoma.HeadNeck2011;33:1260-1264. First study showing a significant decrease of complications and morbidity with SNB compared with SND.
32. Schiefke F, Akdemir M, Weber A, et al. Function, postoperative morbidity, and quality of life after cervical sentinel node biopsy and after selective neck dissection. Head Neck 2009; 31:503-512.
33. Fukui Y, Yamakawa T, Taniki T, et al. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 2001; 92:2868-2874.
34. Stoeckli SJ, Pfaltz M, Steinert H, Schmid S. Sentinel lymph node biopsy in thyroid tumors: a pilot study. Eur Arch Otorhinolaryngol 2003; 260:364-368. (Pubitemid 37100679)
35. Lawson G, Matar N, Nollevaux MC, et al. Reliability of sentinel node technique in the treatment of N0 supraglottic laryngeal cancer. Laryngoscope 2010; 120:2213-2217. Validation study of SNB for supraglottic SCC with excellent accuracy.
36. Flach GB, Broglie MA, van Schie A, et al. Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma in the previously treated neck. Oral Oncol 2011. [Epub ahead of print] First study showing the feasibility of SNB for OSCC in the previously treated neck.
37. Goerkem M, Braun J, Stoeckli SJ. Evaluation of clinical and histomorphological parameters as potential predictors of occult metastases in sentinel lymph nodes of early squamous cell carcinoma of the oral cavity. Ann Surg Oncol 2010; 17:527-535. This study shows that tumor thickness and infiltration depth of the primary tumor lost their predictive value for the presence of occult nodal disease in the context of SNB.
38. Huber GF, Fritzsche FR, Zullig L, et al. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. Int J Cancer 2011; 129:1404-1409.
39. Huber GF, Zullig L, Soltermann A, et al. Down regulation of ECadherin (ECAD): a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer 2011; 11:1-8.
40. Terada A, Hasegawa Y, Yatabe Y, et al. Intraoperative diagnosis of cancer metastasis in sentinel lymph node of oral cancer patients. Oral Oncol 2008; 44:838-843.
41. Tschopp L, Nuyens M, Stauffer E, et al. The value of frozen section analysis of the sentinel lymph node in clinically N0 squamous cell carcinoma of the oral cavity and oropharynx. Otolaryngol Head Neck Surg 2005; 132:99-102. (Pubitemid 40052679)
42. Mitas M, Mikhitarian K, Walters C, et al. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 2001; 93:162-171. (Pubitemid 32574270)
43. Dell'Orto P, Biasi MO, Del Curto B, et al. Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA. Breast Cancer Res Treat 2006; 98:185-190. (Pubitemid 44050768)
44. Hughes SJ, Xi L, Raja S, et al. A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg 2006; 243:389-398. (Pubitemid 43327772)
45. Garrel R, Dromard M, Costes V, et al. The diagnostic accuracy of reverse transcription-PCR quantification of cytokeratin mRNA in the detection of sentinel lymph node invasion in oral and oropharyngeal squamous cell carcinoma: a comparison with immunohistochemistry. Clin Cancer Res 2006; 12:2498-2505.
46. Shores CG, Yin X, Funkhouser W, Yarbrough W. Clinical evaluation of anew molecular method for detection of micrometastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004; 130:937-942. (Pubitemid 39045600)
47. Ferris RL, Xi L, Raja S, et al. Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res 2005; 65:2147-2156. (Pubitemid 40490121)
48. Ferris RL, Xi L, Seethala RR, et al. Intraoperative qRT-PCR for detection of lymph node metastasis in head and neck cancer. Clin Cancer Res 2011; 17:1858-1866. First study showing the real-time feasibility of intraoperative sentinel node assessment with an automated system using molecular markers.
49. Solassol J, Burcia V, Costes V, et al. Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer. Br J Cancer 2010; 102:181-187.
50. Alkureishi LW, Ross GL, Shoaib T, et al. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol 2010; 17:2459-2464. [22]
51. Bender B, Widmann G, Riechelmann H, Schmutzhard J. Hypopharyngeal carcinoma and red ear drum [German]. HNO 2011; 59:376-379.
52. Broglie MA, Haile SR, Stoeckli SJ. Long-term experience in sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Ann Surg Oncol 2011. [Epub ahead of print] [21]
53. Christopoulos A, Ahn SM, Klein JD, Kim S. Biology of vascular endothelial growth factor and its receptors in head and neck cancer: beyond angiogenesis [Review]. Head and Neck 2011; 33:1220-1229.
54. Civantos FJ, Zitsch RP, Schuller DE, et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multiinstitutional trial. J Clin Oncol 2010; 28:1395-1400. [20]
55. Ferris RL, Xi L, Seethala RR, et al. Intraoperative qRT-PCR for detection of lymph node metastasis in head and neck cancer. Clin Cancer Res 2011; 17:1858-1866. [48]
56. Flach GB, Broglie MA, van Schie A, et al. Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma in the previously treated neck. Oral Oncol 2011. [Epub ahead of print] [36]
57. Goerkem M, Braun J, Stoeckli SJ. Evaluation of clinical and histomorphological parameters as potential predictors of occult metastases in sentinel lymph nodes of early squamous cell carcinoma of the oral cavity. Ann Surg Oncol 2010; 17:527-535. [37]
58. Huber GF, Zullig L, Soltermann A, Roessle M, et al. Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx - art. no. 217. BMC Cancer 2011:217.
59. Jefferson GD, Sollaccio D, Gomez-Fernandez CR, Civantos F. Evaluation of Immunohistochemical Fine Sectioning for Sentinel Lymph Node Biopsy in Oral Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2011; 144:216-219.
60. Lawson G, Matar N, Nollevaux MC, et al. Reliability of sentinel node technique in the treatment of N0 supraglottic laryngeal cancer. Laryngoscope 2010; 120:2213-2217. [35]
61. Liu LC, Lang JE, Lu Y, Roe D, et al. Intraoperative Frozen Section Analysis of Sentinel Lymph Nodes in Breast Cancer Patients. Cancer 2011; 117:250-258.
62. Murer K, Huber GF, Haile SR, Stoeckli SJ. Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the N0 neck in patients with oral squamous cell carcinoma. Head Neck 2011; 33:1260-1264. [31]
63. Yoldas B, Ozer C, Ozen O, Canpolat T, et al. Clinical significance of trail and trail receptors in patients with head and neck cancer. Head and Neck 2011; 33:1278-1284.